tiprankstipranks
Trending News
More News >
Imagion Biosystems Ltd. (AU:IBX)
:IBX
Australian Market
Advertisement

Imagion Biosystems Ltd. (IBX) Stock Statistics & Valuation Metrics

Compare
12 Followers

Total Valuation

Imagion Biosystems Ltd. has a market cap or net worth of AU$15.77M. The enterprise value is AU$4.83M.
Market CapAU$15.77M
Enterprise ValueAU$4.83M

Share Statistics

Imagion Biosystems Ltd. has 450,633,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding450,633,850
Owned by Insiders
Owned by Institutions

Financial Efficiency

Imagion Biosystems Ltd.’s return on equity (ROE) is 0.91 and return on invested capital (ROIC) is -110.65%.
Return on Equity (ROE)0.91
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)-110.65%
Return on Capital Employed (ROCE)0.33
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count
Asset Turnover0.95
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Imagion Biosystems Ltd. is ―. Imagion Biosystems Ltd.’s PEG ratio is 0.00563.
PE Ratio
PS Ratio0.39
PB Ratio-0.45
Price to Fair Value-0.45
Price to FCF-0.81
Price to Operating Cash Flow-1.49
PEG Ratio0.00563

Income Statement

In the last 12 months, Imagion Biosystems Ltd. had revenue of 2.67M and earned -2.07M in profits. Earnings per share was -0.05.
Revenue2.67M
Gross Profit2.26M
Operating Income-756.55K
Pretax Income-2.50M
Net Income-2.07M
EBITDA-700.09K
Earnings Per Share (EPS)-0.05

Cash Flow

In the last 12 months, operating cash flow was -2.89M and capital expenditures 0.00, giving a free cash flow of -2.89M billion.
Operating Cash Flow-2.89M
Free Cash Flow-2.89M
Free Cash Flow per Share>-0.01

Dividends & Yields

Imagion Biosystems Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.19
52-Week Price Change33.33%
50-Day Moving Average0.03
200-Day Moving Average0.02
Relative Strength Index (RSI)55.05
Average Volume (3m)15.31M

Important Dates

Imagion Biosystems Ltd. upcoming earnings date is Feb 26, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date

Financial Position

Imagion Biosystems Ltd. as a current ratio of 0.55, with Debt / Equity ratio of -124.72%
Current Ratio0.55
Quick Ratio0.55
Debt to Market Cap2.70
Net Debt to EBITDA-0.25
Interest Coverage Ratio-0.66

Taxes

In the past 12 months, Imagion Biosystems Ltd. has paid -437.28K in taxes.
Income Tax-437.28K
Effective Tax Rate0.17

Enterprise Valuation

Imagion Biosystems Ltd. EV to EBITDA ratio is -1.73, with an EV/FCF ratio of -0.95.
EV to Sales0.45
EV to EBITDA-1.73
EV to Free Cash Flow-0.95
EV to Operating Cash Flow-0.95

Balance Sheet

Imagion Biosystems Ltd. has AU$883.57K in cash and marketable securities with AU$3.30M in debt, giving a net cash position of -AU$2.42M billion.
Cash & Marketable SecuritiesAU$883.57K
Total DebtAU$3.30M
Net Cash-AU$2.42M
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share-AU$0.05

Margins

Gross margin is 84.95%, with operating margin of -28.39%, and net profit margin of -77.56%.
Gross Margin84.95%
Operating Margin-28.39%
Pretax Margin-93.96%
Net Profit Margin-77.56%
EBITDA Margin-26.27%
EBIT Margin-28.05%

Analyst Forecast

The average price target for Imagion Biosystems Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target
Price Target Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-47.02%
EPS Growth Forecast94.37%

Scores

Smart Score7
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis